Literature DB >> 8392477

Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression.

J D Fondell1, A L Roy, R G Roeder.   

Abstract

The thyroid hormone receptor (TR) belongs to the steroid/nuclear receptor superfamily of ligand-inducible transcription factors. Numerous studies using transient transfection assays have demonstrated that in the absence of thyroid hormone (T3), unliganded TR acts as a constitutive repressor of transcription on genes bearing TR-response elements. We examined the molecular mechanism of TR repression in vitro using both HeLa nuclear extracts and purified basal factors. Here, we show that unliganded TR is an active transcriptional repressor, distinct from passive repressors that compete with activators for DNA binding. Repression by TR can be relieved by adding the T3 analog triiodothyroactic acid, suggesting that liganded TR undergoes a conformational change that masks or disrupts the repressor function. Repression by TR is mediated through the basal transcription machinery and can occur independently of previously characterized TATA-binding protein-associated cofactors thought to be involved in either basal repression or activator-dependent transcription. TR inhibits transcription at an early step during preinitiation complex (PIC) assembly, as preassembled PICs are refractory to the inhibitory effects of TR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392477     DOI: 10.1101/gad.7.7b.1400

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  82 in total

1.  In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation.

Authors:  M K Kim; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription.

Authors:  M E Martin; A J Berk
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily.

Authors:  U Dressel; D Thormeyer; B Altincicek; A Paululat; M Eggert; S Schneider; S P Tenbaum; R Renkawitz; A Baniahmad
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Targeted chromatin binding and histone acetylation in vivo by thyroid hormone receptor during amphibian development.

Authors:  L M Sachs; Y B Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

5.  Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor.

Authors:  Shao-Chung Victor Hsia; Yun-Bo Shi
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

6.  Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression.

Authors:  G Achatz; B Hölzl; R Speckmayer; C Hauser; F Sandhofer; B Paulweber
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

7.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB.

Authors:  C W Wong; M L Privalsky
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.

Authors:  B Martin; R Renkawitz; M Muller
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

10.  DNA bending by thyroid hormone receptor: influence of half-site spacing and RXR.

Authors:  K Shulemovich; D D Dimaculangan; D Katz; M A Lazar
Journal:  Nucleic Acids Res       Date:  1995-03-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.